News Daily News Big Drops in LDL Cholesterol With Inclisiran, but US Clinicians Still Await Drug’s Approval Michael O'Riordan March 03, 2021
News Daily News FDA Puts the Kibosh on Canakinumab for Cardiac Indication—at Least for Now Michael O'Riordan November 01, 2018
News Daily News High-Risk Medical Device Approval Process in Europe Inches Towards Transparency Michael O'Riordan July 20, 2018